Tff Pharmaceuticals Inc
NASDAQ:TFFP
| Market Cap (Intraday) | 158.02M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.25 |
| 50-Day MA | $7.53 |
| 200-Day MA | $9.97 |
Tff Pharmaceuticals Inc Stock, NASDAQ:TFFP
3801 South Capital of Texas Highway, Suite 330, Austin, Texas 78704
United States of America
Phone: +1.267.742.3428
Number of Employees: 4
Description
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Austin, TX.